Litcius/Paper detail

Circulating L-arginine predicts the survival of cancer patients treated with immune checkpoint inhibitors

Florent Peyraud, Jean‐Philippe Guégan, D. Bodet, Imane Nafia, L. Fontan, C. Auzanneau, Sophie Cousin, Guilhem Roubaud, Mathilde Cabart, François Chomy, François Le Loarer, Nathalie Chaput, François‐Xavier Danlos, David Planchard, Caroline Even, Mohamed Khettab, Lambros Tsélikas, Benjamin Besse, Fabrice Barlési, Jean‐Charles Soria, Aurélien Marabelle, Alban Bessede, Antoîne Italiano

2022Annals of Oncology72 citationsDOI

Topics & Concepts

MedicineImmune systemInternal medicineOncologyPeripheral blood mononuclear cellCancerImmunotherapyBiomarkerImmunologyChemistryBiochemistryIn vitroCancer Research and TreatmentsImmune cells in cancerCancer Immunotherapy and Biomarkers
Circulating L-arginine predicts the survival of cancer patients treated with immune checkpoint inhibitors | Litcius